Login / Signup

Preference for anti-phospholipase A2 receptor antibody assay in patients with suspected membranous nephropathy: a survey study on medical practice after publication of Japanese Guidelines for Nephrotic Syndrome 2020.

Sho SasakiSayaka ShimizuIzaya NakayaYoshitaka MiyaokaMasahiro KoizumiHiroki NishiwakiTadashi SofueTakuji IshimotoNoriaki KuritaTakehiko Wada
Published in: Clinical and experimental nephrology (2024)
The results of this study suggest that a significant proportion of nephrologists in Japan have no experience in performing anti-PLA2R antibody assays, and that the assays may be hampered by the limited capabilities of the current workplace and the financial burden on facilities and patients.
Keyphrases
  • high throughput
  • healthcare
  • ejection fraction
  • end stage renal disease
  • newly diagnosed
  • primary care
  • prognostic factors
  • clinical practice
  • young adults
  • patient reported outcomes
  • binding protein